Xtalks

In the life sciences, prospective clients choose partners they can trust to reduce the scientific, operational and reputational risk surrounding their work. Because the stakes are so high, buzzwords and surface-level promises won’t win their business; proof will. The more clearly and deeply you demonstrate your technical expertise, the more likely you are to win over serious buyers.

Kenneth Holbourn suggested that standardizing more of downstream purification could reduce process development complexity and support a faster transition into clinical manufacturing. Monoclonal antibodies (mAbs) have benefited from decades of manufacturing experience and increasingly standardized production processes.

We are excited to spotlight Xtalks Featured Community Member Lorraine Dishman, Clinical Operations & Program Delivery Leader, Behind the Protocol™, whose work focuses on translating clinical trial strategy into practical, executable decisions. Drawing on experience across site, CRO and academic settings, she shares how early operational alignment, cross-functional decision-making and a continued focus on the patients behind the protocol can help protect timelines, budgets, quality and trust.

We are excited to spotlight Xtalks Featured Community Member Debanti Sengupta, PhD, Head of Product & Portfolio Strategy, Theranostics, Varian, a Siemens Healthineers company, whose work focuses on product and portfolio strategy in the emerging theranostics field. Read about her interest in more personalized cancer treatment, the importance of keeping pace with developments in radiopharmaceutical therapy and her vision for more accessible and equitable cancer care.

We are excited to spotlight Xtalks Featured Community Member Diksha Gupta, Associate Vice President at Shilpa Biologicals Pvt Ltd., whose work combines scientific expertise with CDMO business development and strategic partnership building.

We are excited to spotlight Xtalks Featured Community Member Sarah Ropp, HBSc, AEMCA, ACP, ADS, CP, Specialist, Paramedic Education at Peel Regional Paramedic Services, whose work brings together prehospital clinical research, frontline paramedic education and operational leadership.

We are excited to spotlight Xtalks Featured Community Member Mohammad Ahsan Fuzail, Senior Engineer I, Automation at Lila Sciences, Inc., whose work sits at the intersection of AI, laboratory automation and scientific discovery. He shares his research and engineering achievements, why polymerase chain reaction remains his favorite life science innovation and how open-source technologies could help lower barriers to scientific exploration. What Are Your Proudest Life Science Achievements?

Life sciences innovation can take many forms, from exploring new approaches to cancer treatment and automating scientific research to improving how clinical trials, quality systems and emergency care operate in practice. The six professionals featured in this edition of Xtalks Featured Community Members work across very different parts of that landscape.

We are excited to spotlight Xtalks Featured Community Member Sai Karthik Baira, IS Business Analyst Qualityat bioMérieux, whose work focuses on digital quality transformation across regulated life sciences operations. He discusses his experience with enterprise quality systems and multi-site digital platforms, along with his vision for predictive, AI-enabled quality management that supports compliance, operational efficiency and patient impact. What Are Your Proudest Life Science Achievements?

In 2026, ongoing life sciences investment in Singapore is adding ADC, biologics, vaccine and drug product manufacturing capacity in Tuas, alongside new laboratory and R&D space at Singapore Science Park. Singapore is home to more than 60 biopharmaceutical manufacturing plants, including facilities run by eight of the world’s 10 largest biopharma companies.